Immunogenicity of infectious bursal disease viruses in chickens.
Cross-protective properties of infectious bursal disease viruses (IBDVs) were studied. Viruses represented different subtypes of serotype 1, including recently isolated viruses (variants), and a serotype 2 virus. Chickens were vaccinated at 3 weeks of age with inactivated vaccines containing 10(5), 10(6), 10(7), or 10(8) mean tissue-culture infectious dose of a given virus and challenged 2 weeks later using either 10(2) or 10(3.5) mean embryo infectious dose (EID50) of either a standard virus or a variant serotype 1 virus. Protection was evaluated at 5 and 10 days post-challenge, based on gross and microscopic lesions, body weight, and bursa/body-weight ratios. The serotype 2 virus did not confer protection on birds challenged with the serotype 1 viruses. Vaccines made of variant viruses at the low doses protected chickens challenged with the high or low doses of either the standard or the variant viruses. Vaccines made of the standard or variant strains at low doses protected against high or low challenge doses of the standard strain. Vaccines made of the high dose of any of the standard strains protected chickens against the variant virus when the low challenge dose (10(2) EID50) was used, but not when the high challenge dose (10(3.5) EID50) was used. The lowest dose of the standard viruses vaccines required to confer protection against the variant virus varied depending on the strain. Results indicated that protection depended on the strain and dose of both the vaccine and challenge viruses and that the variant strains and standard strains share a common protective antigen(s).
Ismail
N M
NM
Food Animal Health Research Program, Ohio Agricultural Research and Development Center, Ohio State University, Wooster 44691.
Saif
Y M
YM
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001284:Atrophy; D001835:Body Weight; D002060:Bursa of Fabricius / Q000473:pathology; D002645:Chickens; D004198:Disease Susceptibility; D007243:Infectious bursal disease virus / Q000276:immunology*; D009500:Neutralization Tests; D009929:Organ Size; D011201:Poultry Diseases / Q000517:prevention & control*; D012088:Reoviridae Infections / Q000517:prevention & control / Q000662:veterinary*; D013047:Specific Pathogen-Free Organisms; D014611:Vaccination / Q000662:veterinary; D015164:Vaccines, Inactivated; D014765:Viral Vaccines
D000914:Antibodies, Viral; D015164:Vaccines, Inactivated; D014765:Viral Vaccines